Medical Advisor - Autoimmune Type Diabetes

Medical Advisor - Autoimmune Type 1 Diabetes page is loaded## Medical Advisor - Autoimmune Type 1 Diabetes locations:
Barcelona time type:
Full time posted on:
Posted Todaytime left to apply:
End Date:
January 30, 2026 (13 days left to apply) job requisition :
R2825932
*
* Location:

** Barcelona  
** Job Type:
** Permanent, Full-time
** About the Job
** We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.

Sanofi has recently embarked on a vast and ambitious journey to develop a best-in-class portfolio of medicines that have the potential to change the practice of medicine for people living with Type 1 Diabetes (T1D), a chronic autoimmune disease affecting close to 50 million people worldwide. Sanofi is proud to be a leader in the T1D space, with a long heritage in insulin and now expanding into immune and cell therapies.
** Our Team
** The Medical Advisor (MA) is responsible for providing fair, balanced, objective, scientific, and educational information to healthcare professionals (HCPs) and other stakeholders. MA serves as a scientific expert and resource for the medical community, supporting the appropriate use of Sanofi products and advancing scientific knowledge in the therapeutic area of Type 1 Diabetes.
** Core Responsibilities*
* * Support Medical Lead in establishing the Glocal Medical Plan and its implementation
* Keeping up-to-date about medical and scientific developments in the autoimmune Type 1 Diabetes field
* Operating in cross-functional teams in agile setting with self-organized teams to support people at risk identification, improve people at risk/patient pathway and remove barriers.
* Working with cross-functional team to leverage an omnichannel approach in the engagement with external experts and orchestrate a high-touch & personalized engagement across different innovative channels (e.g., social media, peer-to-peer communities, websites, online portals, etc.)
* Gathering data and identifying insights from the MSL/ in-field interactions and providing feedback to the cross-functional organization to feed the Medical Glocal strategy (e.g., allowing enhancement of scientific messages, plans, etc.)
* Tailoring engagement to the different segments of stakeholders, based on comprehensive stakeholders’ mapping (incl. KOLs, Endos, other scientific stakeholders) and local go-to-market model.
* Coordinating and directing to right teams any direct requests for ISS, RCT, Managed Access Programs or others
* Supporting Market Access team in driving the access strategy by engaging with regional payers / drug formulary committees and key account decision-makers to drive evidence / clinical value discussions (incl. treatment, health economics)
* Conducting high-touch scientific exchange with experts from key accounts (e.g., KOLs in Centers of Excellence) and beyond (e.g., broader HCP groups/scientific stakeholders outside of Centers of Excellence) to convey a compelling and highly scientific narrative on T1D disease stages, importance of screening and treatment, leveraging innovative story telling techniques.
* Being the trusted scientific partner to key external experts (incl. KOLs, Endos, other scientific stakeholders), establishing and maintaining robust, long-term peer relationships.
* Answering to product-specific questions to enhance the understanding of the scientific and medical value of the treatment and shape the scientific paradigm in T1D.
* Engaging with experts from key accounts (e.g., KOLs and Endos and pediatricians in Centers of Excellence) to share scientific data, answer scientific questions and support them in developing best practices (i.e., on infusion protocols)
* Linking internal partners to external thought leaders for education and research collaboration
* Disseminating…